» Articles » PMID: 38489056

The Movement of Mitochondria in Breast Cancer: Internal Motility and Intercellular Transfer of Mitochondria

Overview
Specialty Oncology
Date 2024 Mar 15
PMID 38489056
Authors
Affiliations
Soon will be listed here.
Abstract

As a major energy source for cells, mitochondria are involved in cell growth and proliferation, as well as migration, cell fate decisions, and many other aspects of cellular function. Once thought to be irreparably defective, mitochondrial function in cancer cells has found renewed interest, from suggested potential clinical biomarkers to mitochondria-targeting therapies. Here, we will focus on the effect of mitochondria movement on breast cancer progression. Mitochondria move both within the cell, such as to localize to areas of high energetic need, and between cells, where cells within the stroma have been shown to donate their mitochondria to breast cancer cells via multiple methods including tunneling nanotubes. The donation of mitochondria has been seen to increase the aggressiveness and chemoresistance of breast cancer cells, which has increased recent efforts to uncover the mechanisms of mitochondrial transfer. As metabolism and energetics are gaining attention as clinical targets, a better understanding of mitochondrial function and implications in cancer are required for developing effective, targeted therapeutics for cancer patients.

Citing Articles

Invisible Bridges: Unveiling the Role and Prospects of Tunneling Nanotubes in Cancer Therapy.

Chen M, Zhao D Mol Pharm. 2024; 21(11):5413-5429.

PMID: 39373242 PMC: 11539062. DOI: 10.1021/acs.molpharmaceut.4c00563.

References
1.
Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M . Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022; 66:15-23. PMC: 9465273. DOI: 10.1016/j.breast.2022.08.010. View

2.
Yang M, Hu X, Bao W, Zhang X, Lin Y, Stanton S . Changing trends and disparities in 5-year overall survival of women with invasive breast cancer in the United States, 1975-2015. Am J Cancer Res. 2021; 11(6):3201-3211. PMC: 8263668. View

3.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

4.
Jones T, Townsend D . History and future technical innovation in positron emission tomography. J Med Imaging (Bellingham). 2017; 4(1):011013. PMC: 5374360. DOI: 10.1117/1.JMI.4.1.011013. View

5.
Wang L, Zhang S, Wang X . The Metabolic Mechanisms of Breast Cancer Metastasis. Front Oncol. 2021; 10:602416. PMC: 7817624. DOI: 10.3389/fonc.2020.602416. View